Alpha-synuclein in Parkinson's disease: molecular pathogenesis and development of genome engineering-based silencing approaches
<p>The ability to reprogram adult somatic cells into induced pluripotent stem cells (iPSCs) and subsequent development of protocols for their differentiation into disease-relevant cell types have enabled in-depth molecular analyses of multiple disease states as hitherto impossible. Parkinson’s...
Main Author: | Heman-Ackah, S |
---|---|
Other Authors: | Wood, M |
Format: | Thesis |
Language: | English |
Published: |
2015
|
Subjects: |
Similar Items
-
Editorial: Biomarkers and Pathogenesis of Alpha-Synuclein in Parkinson's Disease
by: Puyu Li, et al.
Published: (2021-10-01) -
Novel subcellular localization for alpha-synuclein: possible functional consequences
by: Cristina eGuardia-Laguarta, et al.
Published: (2015-02-01) -
Alpha-Synuclein FRET Biosensors Reveal Early Alpha-Synuclein Aggregation in the Endoplasmic Reticulum
by: Fabiana Miraglia, et al.
Published: (2020-08-01) -
Rationale for Therapeutic Silencing of Alpha-Synuclein in Parkinson’s Disease
by: Demetrius M. Maraganore
Published: (2011-05-01) -
Alpha-synuclein as a biomarker of Parkinson’s disease
by: S. N. Pchelina
Published: (2017-02-01)